ABVC BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 66.4%.

Top 25 shareholders own 25.67% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.33%	Eugene Jiang	998,760	US$549.2k	0%	no data
7.28%	Shuling Jiang	872,209	US$479.6k	0%	no data
3.63%	Tsung-Shann Jiang	434,529	US$238.9k	0%	no data
0.6%	Uttam Patil	72,428	US$39.8k	0%	no data
0.6%	Geode Capital Management, LLC	71,607	US$39.4k	29.7%	no data
0.48%	Yoshinobu Odaira	57,758	US$31.8k	0%	no data
0.43%	Chun Chow	52,007	US$28.6k	0%	no data
0.41%	LionGene Corporation	48,761	US$26.8k	0%	no data
0.4%	Hsin-Hui Miao	48,072	US$26.4k	0%	no data
0.39%	The Vanguard Group, Inc.	46,947	US$25.8k	0%	no data
0.35%	Tsang Ming Jiang	41,994	US$23.1k	0%	no data
0.35%	Yen-Hsin Chou	41,956	US$23.1k	0%	no data
0.35%	Yu-Min Chung	41,943	US$23.1k	0%	no data
0.35%	Norimi Sakamoto	41,854	US$23.0k	0%	no data
0.35%	Chang-Jen Jiang	41,847	US$23.0k	0%	no data
0.35%	Che-Wei Hsu	41,723	US$22.9k	0%	no data
0.33%	Avantax Planning Partners, Inc.	39,000	US$21.4k	0%	no data
0.2%	XTX Holdings Limited, Asset Management Arm	23,405	US$12.9k	23.6%	no data
0.16%	Northern Trust Global Investments	19,135	US$10.5k	0%	no data
0.11%	State Street Global Advisors, Inc.	12,900	US$7.1k	0%	no data
0.1%	Two Sigma Securities, LLC, Asset Management Arm	12,397	US$6.8k	0%	no data
0.081%	BioFirst Corporation	9,669	US$5.3k	0%	no data
0.022%	Tower Research Capital Europe Limited	2,623	US$1.4k	-0.87%	no data
0.014%	Rgene Corporation	1,687	US$927.4	0%	no data
0.0084%	Genepro Investment Company	1,012	US$556.3	0%	no data